- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02617888
Effects of Heart Imaging Radiation on DNA Double-Stranded Breaks in Blood Lymphocytes and Hair Follicle Cells
The HEART BREAK Study: Effects of Heart Imaging Radiation on DNA Double-Stranded Breaks in Blood Lymphocytes and Hair Follicle Cells
Purpose
- To investigate the effects of cardiac imaging radiation on the induction of DNA double-strand breaks by enumerating gamma-H2AX foci in blood lymphocytes and plucked hair follicle cells.
- To estimate whether the use of breast shields in cardiac computed tomographic angiography (CCTA) limits the effective radiation exposure of breast tissue.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The primary objective of the study is to analyze blood and hair samples from patients undergoing cardiac imaging to estimate radiation exposure levels as well as their biological effects (i.e. to determine the degree of genotoxicity by measuring the amounts of DNA double-strand breaks).
The secondary objective is to investigate whether the use of in-plane breast shielding in female patients undergoing CT angiography (CCTA) limits the radiation exposure of breast tissue and subsequent DNA damage in blood lymphocytes and hair follicle cells.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Adult male and female adult subjects (age greater than 18 years)
- Referred for cardiac computed tomography angiography (CCTA), myocardial perfusion scintigraphy (MPS), or diagnostic invasive coronary angiography (ICA).
Exclusion Criteria:
- Female patients that identify themselves as pregnant or have a positive pregnancy test prior to cardiac imaging.
- History (present or past) of leukemia or lymphoma.
- History of radiation therapy
- X-ray examination or scintigraphy within the last 72 hours.
- History of coronary revascularization (coronary artery bypass grafting or percutaneous coronary intervention)
- Patients undergoing percutaneous coronary intervention at completion of diagnostic left heart catheterization
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: CCTA Breast Shields
Within female subset, randomization to wearing bismuth breast shield.
|
Breast shield placement (randomized) among women.
Other Names:
|
No Intervention: CCTA No Breast Shields
Within female subset, randomization to wearing no bismuth breast shield (standard of care).
|
|
No Intervention: Observational Arm
Non-females undergoing CTA and subjects undergoing cardiac catheterization and nuclear medicine testing.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of Excess Double-strand DNA Break Foci Per Cell in Peripheral Blood Samples Post-imaging
Time Frame: Change from baseline double strand DNA breaks at 30 minutes post-imaging
|
The amount of excess DNA double-strand break foci per cell after cardiac computed tomographic angiography (CCTA) in female patients with and without breast shields, minus the amount of foci prior to CCTA.
In addition, changes in DNA double-strand breaks from baseline following cardiac testing in the observational arm is being assessed in an observational manner.
|
Change from baseline double strand DNA breaks at 30 minutes post-imaging
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 362425
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Artery Disease
-
Elixir Medical CorporationIstituto Clinico HumanitasActive, not recruitingCoronary Artery Disease | Chronic Total Occlusion of Coronary Artery | Multi Vessel Coronary Artery Disease | Bifurcation of Coronary Artery | Long Lesions Coronary Artery DiseaseItaly
-
Fundación EPICActive, not recruitingCoronary Artery Disease | Left Main Coronary Artery Disease | Left Main Coronary Artery Stenosis | Restenosis, CoronarySpain
-
Peking Union Medical College HospitalNot yet recruitingCoronary Artery Disease | Inflammation | Coronary Artery Disease Progression | Coronary Artery Stenosis | Coronary Artery Restenosis | Inflammatory Disease | Inflammation VascularChina
-
Peking Union Medical College HospitalRecruitingCoronary Artery Disease | Inflammation | Coronary Artery Disease Progression | Coronary Artery Stenosis | Coronary Artery Restenosis | Inflammatory Disease | Inflammation VascularChina
-
IGLESIAS Juan FernandoUniversity of BernNot yet recruiting
-
National Institutes of Health Clinical Center (CC)National Heart, Lung, and Blood Institute (NHLBI)CompletedCoronary Arteriosclerosis | Coronary Artery Disease (CAD) | Obstructive Coronary Artery DiseaseUnited States
-
Barts & The London NHS TrustImperial College London; Brunel UniversityNot yet recruitingCORONARY ARTERY DISEASE
-
Fundación EPICRecruitingCoronary Artery Disease | Coronary Disease | Coronary Occlusion | Left Main Coronary Artery Disease | Coronary Artery StenosisSpain
-
Abbott Medical DevicesCompletedCoronary Artery Disease | Coronary Disease | Coronary Occlusion | Chronic Total Occlusion of Coronary Artery | Coronary Restenosis | Coronary Artery Stenosis | Coronary Artery RestenosisBelgium
-
China National Center for Cardiovascular DiseasesRecruitingLeft Main Coronary Artery DiseaseChina
Clinical Trials on CCTA ~ BREAST SHIELDS
-
Cardio Med Medical CenterUniversity of Targu Mures, Romania; University Hospital of Targu Mures, RomaniaCompletedAtherosclerosis | Acute Coronary Syndrome | Coronary Stenosis | Acute Myocardial Infarction | Atheromatous PlaquesRomania
-
State University of New York at BuffaloCompletedAtherosclerosis, CoronaryUnited States
-
Tianjin Chest HospitalRecruitingCoronary Artery Disease | Major Adverse Cardiovascular Events | Coronary Computed Tomography Angiography | Revascularization | Stable Chest Pain | Optimal Medical Therapy | Invasive Coronary AngiographyChina
-
Fondazione C.N.R./Regione Toscana "G. Monasterio...Turku University Hospital; University of Zurich; Federico II University; Institute... and other collaboratorsCompletedManagement/Treatment of Coronary Artery Disease
-
Aristotle University Of ThessalonikiUnknownCoronary Artery Disease | Atherosclerosis | Stable Angina | Atherosclerotic PlaqueGreece
-
Washington University School of MedicineCompletedCoronary Artery DiseaseUnited States
-
University of LouisvilleNot yet recruitingMyocardial InjuryUnited States
-
University of MichiganCompletedCoronary Artery Disease | PsoriasisUnited States
-
AHEPA University HospitalUniversity of Zurich; New York UniversityCompletedAngina Pectoris | Ischemic Heart Disease | Coronary Microvascular Disease | Acute Myocardial Infarction | Non-Obstructive Coronary AtherosclerosisGreece
-
HeartFlow, Inc.Duke Clinical Research Institute; Cardiovascular Research Foundation, New YorkCompletedCoronary Artery DiseaseUnited States